PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 67 filers reported holding PASSAGE BIO INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,661,971 | -30.1% | 10,124,576 | 0.0% | 0.14% | -17.9% |
Q2 2023 | $9,530,263 | +11.4% | 10,124,576 | +13.4% | 0.17% | +3.0% |
Q1 2023 | $8,554,175 | -30.6% | 8,931,999 | 0.0% | 0.17% | -28.8% |
Q4 2022 | $12,326,159 | +10.4% | 8,931,999 | 0.0% | 0.24% | +14.0% |
Q3 2022 | $11,165,000 | -47.0% | 8,931,999 | 0.0% | 0.21% | -45.8% |
Q2 2022 | $21,080,000 | -7.3% | 8,931,999 | +21.8% | 0.38% | +3.5% |
Q1 2022 | $22,729,000 | -48.6% | 7,331,999 | +5.3% | 0.37% | -35.0% |
Q4 2021 | $44,214,000 | -36.2% | 6,962,899 | 0.0% | 0.57% | -25.5% |
Q3 2021 | $69,350,000 | -24.8% | 6,962,899 | 0.0% | 0.76% | -18.2% |
Q2 2021 | $92,189,000 | -24.3% | 6,962,899 | 0.0% | 0.93% | -18.1% |
Q1 2021 | $121,711,000 | -31.6% | 6,962,899 | 0.0% | 1.14% | -27.0% |
Q4 2020 | $178,041,000 | +95.0% | 6,962,899 | 0.0% | 1.56% | +35.8% |
Q3 2020 | $91,284,000 | -52.0% | 6,962,899 | 0.0% | 1.15% | -57.2% |
Q2 2020 | $190,296,000 | +73.5% | 6,962,899 | 0.0% | 2.68% | +45.4% |
Q1 2020 | $109,666,000 | – | 6,962,899 | – | 1.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |